Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

84 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions
Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 30 locations
View Trial Details
Completed

Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma

NCT00073749

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • UAB CCC Clinical Studies Unit Birmingham, Alabama, United States
  • University of Alabama at Birmingham Kirklin Clinic Birmingham, Alabama, United States
  • UAB Russell Ambulatory Pharmacy Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
View all 22 locations
View Trial Details
Completed

A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)

NCT01414855

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • cCare Encinitas, California, United States
  • University of Colorado Cancer Center Department of Hematology Aurora, Colorado, United States
  • Rocky Mountain Cancer Ctr - Denver (Williams) Denver, Colorado, United States
View all 38 locations
View Trial Details
Completed

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00867087

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Loyola University Medical Center, Foster G. McGraw Hospital and Satellites Maywood, Illinois, United States
  • Tufts Medical Center Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Siteman Cancer Center City of Saint Peters, Missouri, United States
View all 35 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01421667

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 34 locations
View Trial Details

Related conditions